Rodriguez Natalia M, Linnes Jacqueline C, Fan Andy, Ellenson Courtney K, Pollock Nira R, Klapperich Catherine M
†Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States.
‡Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, United States.
Anal Chem. 2015 Aug 4;87(15):7872-9. doi: 10.1021/acs.analchem.5b01594. Epub 2015 Jul 15.
The 2009 Influenza A (H1N1) pandemic disproportionately affected the developing world and highlighted the key inadequacies of traditional diagnostic methods that make them unsuitable for use in resource-limited settings, from expensive equipment and infrastructure requirements to unacceptably long turnaround times. While rapid immunoassay diagnostic tests were much less costly and more context-appropriate, they suffered from drastically low sensitivities and high false negative rates. An accurate, sensitive, and specific molecular diagnostic that is also rapid, low-cost, and independent of laboratory infrastructure is needed for effective point-of-care detection and epidemiological control in these developing regions. We developed a paper-based assay that allows for the extraction and purification of RNA directly from human clinical nasopharyngeal specimens through a poly(ether sulfone) paper matrix, H1N1-specific in situ isothermal amplification directly within the same paper matrix, and immediate visual detection on lateral flow strips. The complete sample-to-answer assay can be performed at the point-of-care in just 45 min, without the need for expensive equipment or laboratory infrastructure, and it has a clinically relevant viral load detection limit of 10(6) copies/mL, offering a 10-fold improvement over current rapid immunoassays.
2009年甲型H1N1流感大流行对发展中世界的影响尤为严重,凸显了传统诊断方法的主要不足,这些不足使其不适用于资源有限的环境,从昂贵的设备和基础设施要求到长得令人无法接受的周转时间。虽然快速免疫分析诊断测试成本低得多且更适合实际情况,但它们的灵敏度极低,假阴性率很高。在这些发展中地区,需要一种准确、灵敏、特异,同时快速、低成本且独立于实验室基础设施的分子诊断方法,以进行有效的即时检测和流行病学控制。我们开发了一种基于纸的检测方法,该方法允许通过聚醚砜纸基质直接从人类临床鼻咽标本中提取和纯化RNA,在同一纸基质内直接进行H1N1特异性原位等温扩增,并在侧流条上进行即时视觉检测。完整的样本到结果检测可在即时护理点仅用45分钟完成,无需昂贵设备或实验室基础设施,其临床相关病毒载量检测限为10(6)拷贝/毫升,比当前的快速免疫分析有10倍的改进。